Simplify Asset Management »

4d Molecular Therapeutics In shares owned by Simplify Asset Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $656k 70k 9.31

More positions owned by Simplify Asset Management

Simplify Exchange Traded Fun Government Money (SBIL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Simplify Exchange Traded Fun Us Eqt Pls Upsid (SPUC)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Simplify Exchange Traded Fun Multi Qis Altern (QIS)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Simplify Exchange Traded Fun Treasury Opt Inc (BUCK)
Simplify Exchange Traded Fun Natl Muni Bd Etf (NMB)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Simplify Exchange Traded Fun Next Intangible (NXTI)
United Therapeutics Corporation (UTHR)
Align Technology (ALGN)
Eli Lilly & Co. (LLY)

View all positions for Simplify Asset Management

Top funds holding 4d Molecular Therapeutics In

Henderson Group
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
BVF
State Street Corporation
Armistice Capital
Federated Investors
Trails Edge Capital Partners
Adage Capital Partners GP
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In